Tumour microvessel endothelial cell KIT and stem cell factor expression in human solid tumours.

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• The KIT receptor tyrosine kinase and its ligand, stem cell factor (SCF), play roles in cell growth and differentiation.
• Understanding their expression in tumor microvasculature is crucial for cancer biology.

Purpose of the Study:

• To investigate the expression of KIT and SCF in the endothelial cells of tumor microvessels.
• To correlate these expressions with specific tumor types and patient survival outcomes.

Main Methods:

• Immunohistochemistry and in situ hybridization were used to detect KIT and KIT messenger RNA.
• Analysis included 248 human tumors across 15 histological types.

Main Results:

• Moderate to strong KIT expression in tumor endothelial cells was observed in 11 of 15 tumor types, notably glioblastoma, embryonal carcinoma, and renal clear cell carcinoma.
• SCF expression was infrequent in tumor endothelial cells but common in perinecrotic tumor cells.
• In glioblastoma, moderate to strong endothelial KIT expression correlated with more favorable survival (P=0.024), while tumor SCF expression was associated with unfavorable outcomes (P=0.034).

Conclusions:

• Intratumoral microvessels in various human malignant tumors express KIT.
• Tumor cell SCF expression and lack of significant endothelial KIT expression are identified as new adverse prognostic indicators in glioblastoma.